Regulation by interferon β-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients

Neurochemistry International

Volumn 42, Issue 1, 2003, Pages 67-71

  Lucas, Miguel ^a   Rodríguez, María C ^a   Gata, Jose M ^a   Zayas, María D ^a   Solano, Francisca ^a   Izquierdo, Guillermo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Interferon 1a; Lymphocytes; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; LYMPHOCYTE; MONOCYTE; MULTIPLE SCLEROSIS; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; DITHIONITROBENZOIC ACID; FEMALE; FREE RADICALS; HUMANS; INTERFERON-BETA; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; TETRADECANOYLPHORBOL ACETATE;

EID: 0037210372     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00057-8     Document Type: Article

References (16)

1. Calabrese V., Bella R., Testa D., Spadaro F., Scrofani A., Rizza V., Pennisi G. Increased cerebroespinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid soluble fluorescence in MS: the pathogenic role of oxidative stress. Drugs Exptl. Clin. Res. XXIV:1998;125-131.
2. Comi, G., Filippi, M., Barkhof, et al., 2001. Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomised study. Lancet 357, 1576-1582.
3. Colton C.A., Yao J., Keri J.E., Gilbert D. Regulation of microglial function by interferons. J. Neuroimmunol. 40:1992;89-98.
4. Halliwell B., Gutteridge M.C. Oxygen radicals and the nervous system. Trends Neurosci. 8:1985;22-29.
5. Jacobs L.D., Beck R.W., Simon J.H.et al. Intramuscular interferon β-1a therapy initiated during a first demyelinating event in multiple sclerosis. N. Engl. J. Med. 343:2000;898-904.
6. Knight J.A. Reactive oxygen species and the neurodegenerative disorders. Ann. Clin. Lab. Sci. 27:1997;11-25.
7. Konat G.W., Wiggins R.C. Effect of reactive oxygen species on myelin membrane proteins. J. Neurochem. 45:1985;1113-1118.
8. LeVine S.M. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med. Hyp. 39:1992;271-274.
9. Lorber A., Pearson C.M., Meredith W.L., Gantz-Mandell L.E. Serum sulfhydryl determinations and significance in connective tissue diseases. Ann. Int. Med. 61:1964;423-434.
10. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., Kalman B. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177:2000;95-103.
11. Lucas M., Solano F. Determination of the myeloperoxidase-hydrogen peroxide-halide system activity following the respiratory burst of human neutrophils. Biomed. Biochim. Acta. 49:1990;45-50.
12. Lucas M., Izquierdo G., García-Soliño O., Solano F. Interferon β-1b inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis. Neurochem. Int. 33:1998;101-102.
13. Lucas M., Bellido L., Dinca L., Solano F., Zayas M.D., Izquierdo G. The oxidation-reduction state of serum proteins in multiple sclerosis patients: effect of interferon β-1b. Neurochem. Int. 34:1999;287-289.
14. Lucchinetti C., Brück W., Parisi J., Scheithaur B., Rodríguez M., Lassmannn H. Heterogeneity of multiple sclerosis lesions: implication for the pathogenesis of demyelination. Ann. Neurol. 47:2000;707-717.
15. van der Goes A., Brouwer J., Hoekstra K., Roos D., van der Berg T.K., Dijkstra C.D. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J. Neuroimmunol. 92:1998;67-75.
16. Vladimirova O., O'Connor J., Cahill A., Butunoi C., Kalman B. Oxidative damage to DNA in plaques of MS brains. Mult. Scler. 4:1998;413-418.